An In-Depth Examination of Formularies and Other Features
of Medicare Drug Plans
This study examines formularies, drug costs and utilization management tools in drug plans offered by 14 national and near-national organizations. Collectively, these organizations account for 1,222 of the 1,429 packages available to Medicare beneficiaries.
The analysis finds that Medicare’s new, private, stand-alone drug plans vary significantly in terms of covered drugs, out-of-pocket costs for specific medications and restrictions placed on the use of certain drugs.
The study was conducted by Jack Hoadley of Georgetown University, Elizabeth Hargrave of the National Opinion Research Center at the University of Chicago, and Juliette Cubanski and Tricia Neuman of the Kaiser Family Foundation.
also of interest
- Financial and Administrative Alignment Demonstrations for Dual Eligible Beneficiaries Compared: States with Memoranda of Understanding Approved by CMS
- Medicare at a Glance
- Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006
- Understanding The Effects of The Medicare Part D Coverage Gap in 2008 and 2009